Maybe the US will be shut out of Leronlimab. UK
Post# of 148165
UK seems much more interested. Now that AZ is out of the race, and GSK behind, they don't really have a dog in this hunt anymore... Why would they want any of the US's Big Pharmas to get any bigger? Answer: they don't. They get LLmab and wreck, at minimum, GILD... win win, for UK.